BAUSCH AND LOMB Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BAUSCH AND LOMB, and what generic alternatives to BAUSCH AND LOMB drugs are available?
BAUSCH AND LOMB has eighty-three approved drugs.
There are forty-nine US patents protecting BAUSCH AND LOMB drugs.
There are four hundred and seventy-six patent family members on BAUSCH AND LOMB drugs in forty-seven countries and eighty-one supplementary protection certificates in fifteen countries.
Summary for BAUSCH AND LOMB
| International Patents: | 476 |
| US Patents: | 49 |
| Tradenames: | 76 |
| Ingredients: | 58 |
| NDAs: | 83 |
Drugs and US Patents for BAUSCH AND LOMB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb Inc | OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 206087-001 | Dec 5, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Bausch And Lomb | TIMOLOL MALEATE | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 074778-001 | Mar 25, 1997 | AT1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bausch And Lomb | LEVOBUNOLOL HYDROCHLORIDE | levobunolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 074307-001 | Mar 4, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Bausch And Lomb Inc | LACRISERT | hydroxypropyl cellulose | INSERT;OPHTHALMIC | 018771-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BAUSCH AND LOMB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch And Lomb Inc | TIMOPTIC | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 018086-001 | Approved Prior to Jan 1, 1982 | 3,655,663 | ⤷ Sign Up |
| Bausch And Lomb Inc | XIBROM | bromfenac sodium | SOLUTION/DROPS;OPHTHALMIC | 021664-001 | Mar 24, 2005 | 4,910,225 | ⤷ Sign Up |
| Bausch And Lomb Inc | TIMOPTIC | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 018086-002 | Approved Prior to Jan 1, 1982 | 3,655,663 | ⤷ Sign Up |
| Bausch And Lomb | LOTEMAX | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 020583-001 | Mar 9, 1998 | 4,996,335*PED | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for BAUSCH AND LOMB drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Ophthalmic Solution | 0.07% | ➤ Subscribe | 2013-07-26 |
| ➤ Subscribe | Ophthalmic Solution | 0.5% | ➤ Subscribe | 2012-10-19 |
| ➤ Subscribe | Ophthalmic Solution | 1.5% | ➤ Subscribe | 2013-09-09 |
International Patents for BAUSCH AND LOMB Drugs
Supplementary Protection Certificates for BAUSCH AND LOMB Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0957929 | C 2007 038 | Romania | ⤷ Sign Up | PRODUCT NAME: 5'-ESTERUL((2'-DEOXI-2'-FLUORO)C-GM-GM-A-A-(2'-DEOXI-2'-FLUORO)U-(2'-DEOXI-2'-FLUORO)C-AM-GM-(2'-DEOXI-2'-FLUORO)U-GM-AM-AM-(2'-DEOXI-2'-FLUORO)U-GM-(2'-DEOXI-2'-FLUORO)C-(2'-DEOXI-2'-FLUORO)U-(2'-DEOXI-2'-FLUORO)U-AM-(2'-DEOXI-2'-FLUORO)U-AM-(2'-DEOXI-2'-FLUORO)C-AM-(2'-DEOXI-2'-FLUORO)U-(2'-DEOXI-2'-FLUORO)C-(2'-DEOXI-2'-FLUORO)C-GM-(3'-3')-DT)CUALFA,ALFA'-[(1S)-1-[(5-(FOSFOONOXI)PENTIL]CARBAMOIL]PENTAN-1,5-DIIL]BIS(IMINOCARBONIL)]BIS[OMEGA-METOXIPOLI(OXIETAN-1,2-DIIL)], DE PREFERINTA SUB FORMA SARII DE SODIU - PEGAPTANIB, DE PREFERINTA SUB FORMA SARII DESODIU; NATIONAL AUTHORISATION NUMBER: EU/1/05/325/001; DATE OF NATIONAL AUTHORISATION: 20060131; NUMBER OF FIRST AUT [...] |
| 1586316 | C300494 | Netherlands | ⤷ Sign Up | PRODUCT NAME: BROMFENAC, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF HYDRAAT; REGISTRATION NO/DATE: EU/1/11/692/001 20110518 |
| 3043773 | 2190041-0 | Sweden | ⤷ Sign Up | PRODUCT NAME: MOMETASONE OR A SALT THEREOF AND OLOPATADINE OR A SALT THEREOF; NAT. REG. NO/DATE: MT NR 60226 20210519; FIRST REG.: AT APPROVAL NR 140638 20210426 |
| 0694547 | SPC/GB02/027 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: 2-(2-AMINO-1,6-DIHYDRO-6-OXO-PURIN-9-YL)-METHOXY-3-HYDROXY-1-PROPANYL-L-VALINATE HYDROCHLORIDE (VALGANCICLOVIR HYDROCHLORIDE); REGISTERED: NL RVG 25992 20010920; UK PL 00031/0599 20020425 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
